No front page content has been created yet. Follow the User Guide to start building your site.
Subscribe to
ADCETRIS® (brentuximab vedotin) is an antibody drug conjugate designed to target cells expressing CD30, a key biomarker in peripheral T-cell lymphomas and classical Hodgkin lymphoma.
-5.png)
